Working memory failure by combined blockade of muscarinic and β- adrenergic transmission in the rat hippocampus

NeuroReport

Volumn 8, Issue 7, 1997, Pages 1571-1575

  Ohno, Masuo ^a   Kobayashi, Masako ^a   Kishi, Akihiro ^a   Watanabe, Shigenori ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Acetylcholine; D Cycloserine; Hippocampus; Muscarinic receptor; NMDA receptor; Noradrenaline; Propranolol; Scopolamine; Working memory; Adrenoceptor

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOSERINE; PHYSOSTIGMINE; PROPRANOLOL; SCOPOLAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TASK PERFORMANCE; WORKING MEMORY;

EID: 0030960688     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199705060-00005     Document Type: Article

References (26)

1. Decker MW and Gallagher M. Brain Res 417, 59-69 (1987).
2. Decker MW, Gill TM and McGaugh JL. Brain Res 513, 81-85 (1990).
3. Riekkinen P Jr, Sirviö J, Ekonsalo T et al. Brain Res Bull 28, 919-922 (1992).
4. Kobayashi M, Ohno M, Yamamoto T et al. Physiol Behav 58, 307-314 (1995).
5. Ohno M, Yamamoto T, Kobayashi M et al. Eur J Pharmacol 238, 117-120 (1993).
6. Ohno M, Yamamoto T and Watanabe S. J Pharmacol Exp Ther 263, 943-950 (1992).
7. Ohno M, Kishi A and Watanabe S. Neurosci Lett 217, 21-24 (1996).
8. Ohno M and Watanabe S. Eur J Pharmacol 318, 267-271 (1996).
9. Ohno M and Watanabe S. Neuroscience 70, 303-311 (1996).
10. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, 1982.
11. Kitajima I, Yamamoto T, Ohno M et al. Jpn J Pharmacol 58, 175-183 (1992).
12. Ohno M, Yoshimatsu A, Kobayashi M et al. Pharmacol Biochem Behav (in press).
13. Harrell LE, Peagler A and Parsons DS. Pharmacol Biochem Behav 35, 21-28 (1990).
14. Bliss TVP and Collingridge GL. Nature 361, 31-39 (1993).
15. Collingridge GL and Bliss TVP. Trends Neurosci 10, 288-293 (1987).
16. Abe K, Nakata A, Mizutani A et al. Neuropharmacology 33, 847-852 (1994).
17. Markram H and Segal M. J Physiol 427, 381-393 (1990).
18. Fishkin RJ, Ince ES, Carlezon WA Jr et al. Behav Neural Biol 59, 150-157 (1993).
19. Sirviö J, Ekonsalo T, Riekkinen P Jr et al. Neurosci Lett 146, 215-218 (1992).
20. Lacaille J-C and Harley CW. Brain Res 358, 210-220 (1985).
21. Stanton PK and Sarvey JM. Brain Res 361, 276-283 (1985).
22. Burgard EC, Decker G and Sarvey JM. Brain Res 482, 351-355 (1989).
23. Dahl D and Sarvey JM. Brain Res 528, 347-350 (1990).
24. Ohno M, Yoshimatsu A, Kobayashi M et al. Eur J Pharmacol 307, 21-26 (1996).
25. Bröcher S, Artola A and Singer W. Brain Res 573, 27-36 (1992).
26. Kobayashi M, Ohno M, Shibata S et al. Soc Neurosci Abstr 22, 330 (1996).